Health Care

Insider CFO buys 13,605 shares at $0.12 amid 326 % weekly surge, signaling confidence in Inspira’s upcoming respiratory tech and potential long‑term upside.

Juniper Investment Company’s latest 3.2 M-share holding of Orthofix Medical signals institutional confidence amid a volatile market and ongoing governance scrutiny, offering investors a potential long‑term play despite current headwinds.

UHS insider moves reveal family trust re‑allocations with no market impact, highlighting stability but no fresh capital for growth.

Insider buying surge at Streamex Corp. signals bullish momentum—understand why the chairman’s disciplined purchases and GLDY token platform could boost stock value.

Investor insight: Natera insider sales are tax‑driven and don’t weaken the company’s strong biotech fundamentals and pipeline growth.

JW Asset Management’s recent sell‑off of 25,320 ELHC shares reveals a deliberate portfolio rebalancing amid a 112 % year‑to‑date rally, signaling strategic profit‑realisation and potential supply pressure while underscoring ELHC’s solid growth funda…

Insider buying spurs confidence in Rein Therapeutics, but investors face volatility as the company’s pipeline and valuation remain uncertain.

Insider confidence in Aptevo’s Niowave partnership signals a high‑risk, high‑reward upside; insiders’ RSU purchases suggest long‑term conviction amid volatile, discounted stock.

Polaryx CEO’s 88k‑share purchase signals hidden confidence amid a 91% drop—why investors should weigh insider faith against biotech risk.

Tenet Healthcare insider buys 1,188 RSUs on May 27, showing board’s long‑term confidence and a value‑seeking opportunity as the stock trades near a 52‑week low.